Introduction: We present a Trajectory-based Volumetric Modulated Arc Therapy (TVMAT) technique for Stereotactic Radiosurgery (SRS) that takes advantage of a modern linacs ability to modulate dose rate and move the couch dynamically. In addition, we investigate the quality of the developed TVMAT method and the dosimetric accuracy of the technique. Methods: The main feature of the TVMAT technique is a standard beam trajectory formed by dynamic motion of the treatment couch and the linac gantry. The couch rotates slowly through 180 degrees while the gantry delivers radiation through continuous sweeps of the gantry. The number of partial arcs that constitute the trajectory can be varied between two and eight and as the number of partial arcs increases, the trajectory more finely samples 4p geometry. Along these trajectories, the multi-leaf collimator (MLC) and dose rate are optimized through an inverse planning framework. The TVMAT method was tested on ten cranial SRS patients who were previously treated with the Dynamic Conformal Arc (DCA) technique. The plans were compared with the DCA and a four-arc VMAT technique with regards to dose to the OAR, dose falloff, V12Gy, and V4Gy. Validation measurements were performed using ion-chamber and Gafchromic film. In addition, the trajectory-log files were analyzed and compared with the treatment plan beam data. Results: The TVMAT treatment plans were successfully delivered with a treatment time between 3-8 min which mostly depended on total cumulated dose. Ion chamber measurements had an average measured error of 1.1 AE 0.6% and a maximum value of 2.2% of the delivered dose. The 2%, 2 mm gamma pass rates for the film measurements were 96% or greater. In a preliminary comparison of ten patients who underwent SRS treatments with the DCA technique, the TVMAT and VMAT techniques were able to produce plans with comparable dose falloff and OAR doses, while achieving better dose conformality, V4Gy and V12Gy when compared to the original DCA plans. The improvement of the TVMAT plans were as follows (mean % improvement AE standard err): Conformity (10 AE 2%), V4 (20 AE 20%), V12 (27 AE 10%), volume weighted mean dose to organs at risk (13 AE 13%), homogeneity index (2 AE 2%) and falloff (4 AE 2%). Conclusion: We have developed and validated a trajectory-based dose delivery method which has dose distribution improvements while having a treatment time of 3-8 min. In addition, it has the potential for a simpler planning experience while maintaining an accurate delivery on the Varian Truebeam Linac.
INTRODUCTION
In cranial stereotactic radiosurgery (SRS), highly conformal ablative radiation is delivered to small, well-defined targets in the brain in a single fraction. For an SRS technique to be successful, dose to the target should be highly conformal with rapid dose falloff outside the lesion. Commonly used treatment modalities for these deliveries include specialized devices such as Gamma Knife and CyberKnife, 1 as well as conventional C-arm linear accelerators. In conventional C-arm linacs, the high degree of target dose conformality and rapid dose falloff are achieved with multiple beam entrance angles that are typically accomplished with non-coplanar arcs. Two arc techniques, Dynamic Conformal Arcs (DCA) 2, 3 and Volumetric Modulated Arc Therapy (VMAT) 4, 5 are used to achieve these dosimetric objectives.
The DCA technique is a forward planning method that becomes increasingly complicated to plan and deliver when there are multiple targets, as is typical in the treatment of brain metastases. Recently, VMAT is becoming increasingly adopted for treating multiple metastases with SRS 4, 5 as it uses an inverse planning strategy. However, non-coplanar VMAT can be cumbersome to plan and deliver since multiple couch re-positionings are required and the number of arcs and the planes of inclination of the arcs are not considered during optimization. This work tries to mitigate these shortfalls by the use of simultaneous couch and gantry motion that enables a time-efficient delivery while affording the planning algorithm a large portion of the couch-gantry phase space.
The use of simultaneous couch and gantry motion for SRS was first introduced in 1988 by Podgorsak and his colleagues at McGill University. 6 Although their method was found to have dosimetric and treatment time saving benefits, it did not gain a wide acceptance as none of the major linac manufacturers adopted the technology. As linac manufactures opened up the degrees of freedom of the device, there came a renewed interest in this field. The first of which was conducted by Yang et al. 7 who devised a method to create dynamic couch-gantry trajectories by implementing an algorithm which minimizes beam overlap with Organs at Risk (OARs). This was accomplished by creating a beam overlap metric for each couch and gantry combination and then finding smooth paths through phase space which minimizes this metric. Macdonald 8 and Smyth 9 applied this method in the cranial SRS case and found that the method successfully improved target dose conformality and lowered doses to OARs when compared with standard VMAT plans. However, these trajectories were not necessarily time-efficient or dosimetrically optimal as they were predefined before MLC and dose rate modulation. In addition, they involved sporadic couch movements, which are both uncomfortable, can result in intra-fraction motion and require complex quality assurance (QA) protocols. While previous methods [7] [8] [9] successfully presented the dosimetric benefits of a trajectory-based delivery, they did not systematically study the dosimetric benefits of trajectory modulation. It is therefore difficult to assess whether the dosimetric benefits of trajectory-based deliveries were fully utilized by these methods. A different approach to trajectory-based delivery is the 4p non-coplanar radiotherapy technique in which a column generation method is used to optimize beam entrance angles and fluence maps on a full 4p solid angle space. 10 The 4p technique has been shown to have dosimetric advantage over VMAT technique in Stereotactic Body Radiotherapy of lung and liver lesions, 11, 12 as well as in the treatment of glioblastoma. 13 However, the 4p technique results in increased delivery time since it typically involves 15-20 non-coplanar static beams.
In this work, we propose and validate a method that uses a patient-generalized trajectory that approaches 4p geometry and thus approximates a fully sampled trajectory. We also present preliminary analysis on creating time optimal trajectories, while still maintaining the treatment plan quality by developing methods which systematically remove portions of the beam trajectory while not significantly contributing to the dose delivery. These treatments were compared to the dynamic conformal arc method and were dosimetrically validated by delivery on the TrueBeam linac via TrueBeams Developer Mode.
METHODS

2.A. Optimization
The developed optimization protocol has three main components (illustrated in Fig. 1 ). Firstly, [ Fig. 1(a) ] a patient-generalized trajectory is constructed which is well suited for cranial indications. Next [ Fig. 1(b) ], this trajectory is fed into an optimization framework which optimized MLC and dose rate configurations along the input trajectory. Lastly, the spatial sampling frequency is optimized to ensure a time efficient delivery [ Fig. 1(c)-1(d) ]. These three features combine to produce both a dosimetrically optimal and time efficient trajectory. The details will be discussed below.
2.A.1. The couch-gantry trajectory
The central feature of this method is the Couch-Gantry trajectory in which the couch rotates through 180 degrees while the gantry makes two to eight partial arc sweeps across the cranium (illustrated in Fig. 1 ). As the number of partial arcs increases and the beams begin to overlap, this trajectory increasingly samples 4p geometry. The trajectory is patient generalized which has a reproducible beam geometry for patient specific QA. In addition, while this trajectory allows complete sampling of the phase space, plans are optimized to be patient specific by variable MLC positions and dose rates which are made to provide maximal OAR sparing and conformity to the target.
The Couch-Gantry Trajectory is formed using a trajectory generating function
where G is the gantry angle, C is the couch angle [on the interval (À90, 90)], and N is the number of partial gantry arcs (coordinates defined in IEC 61217 14 ) . For illustration of this technique, refer to ( Fig. 1) , when N is set to 3, the trajectory in Figs. 1(c) and 1(d) is produced while when N is set to 8 the trajectory in Figs. 1(a) and 1(b) is created. The scaling factor of 85 was used to remove the overlap of beams when the gantry is positioned vertically.
2.A.2. Dose rate and MLC modulation
Treatment plans were optimized using in-house software which was written in MATLAB and based on the progressive sampling algorithm described by Otto 15 and was later implemented in the TrueBeam STx linac. The base trajectories were loaded into the optimizer as a set of static control points which designate couch and gantry positions. The optimizer set up the initial condition of optimization by sparsely sampling the trajectory at a reduced set of control points which were evenly spaced by 40 degrees. At these control points, the MLC (Varian HD120) was set to conform to the target with a 0 mm margin. Doses for each control point were calculated using an in-house MATLAB implementation of the pencil beam convolution algorithm. Doses were calculated only for critical structures, and for normal tissue within a 3 cm margin around the PTV so as to reduce computation time. Control point doses were uniformly scaled such that the target was covered by the prescription isodose. Once each control point was initialized, a scalar cost function was evaluated which related the dose delivered to clinical variables of interest.
Next, the initial control points were perturbed stochastically in MLC position and dose rate (DR). Initially, perturbations were large to ensure the plans avoided local minima; however, as optimization progressed, perturbation sizes were linearly decreased so that minimal cost values could be found. After each perturbation, the cost function was re-evaluated, and if the perturbation was found to reduce the cost function, it was kept. Otherwise the previous value was retained, and a subsequent perturbation was resampled. As optimization progressed, new control points were introduced as linear interpolations of the adjacent control points so as to ensure a continuous delivery. 15 Additionally, the physical limitations of the device were taken into consideration for the sampling of the perturbations: only MLC and DR perturbations which could be physically achieved in a continuous gantry-couch arc were sampled from. For MLC positions, this was defined by the max velocity and for DR, this was the maximal dose rate given the beam settings. The optimization was conducted for 20 min with additional control points being added in evenly spaced increments of 3 couchgantry degrees.
2.A.3. Delivery time optimization
Delivery time was optimized by variably sampling the phase space and calculating competing plans. If the plans redundantly sampled the phase space due to the beam trajectories overlapping, then the treatment time would be increased unnecessarily. To find the time optimal sampling of the phase space, couch-gantry trajectories with varying numbers of partial arcs were constructed. At first, eight partial arcs were used as this corresponds to a near-complete sampling of the phase space and gives the treatment planning algorithm a benchmark to compare other plans against. Next, the number of partial arcs (N) were varied between eight partial arcs [ Fig. 1(a) , a near-complete sampling of the phase space] to two partial arcs (a Podgorsak trajectory 6 ) in an increment of 0.5 arcs. Each of these plans were optimized and then compared. The plan which provided the most sparse sampling of the phase space while producing the same dosimetric result was selected.
2.A.4. Cost function calculation
The cost function was designed to include the most clinically relevant variables for SRS delivery: doses to OAR, PTV dose conformity, and dose falloff. Doses to OARs were represented as user assigned dose-volume constraints and relative importance factors. The calculation of the cost (C) was conducted using the following equation:
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where CI is the calculated conformity index, CI Con is the optimal conformity index (which was set to 1.0), FO is the calculated dose falloff, FO Con is the constraint falloff (which was set to 2.0), and w i is the weight for a particular DVH constraint which was set to unity for this treatment planning study and judicially changed if needed. Dose to OAR and PTV as a function of DVH values were assigned a weight of 0.5 of the cost associated with a particular plan, while conformity and dose falloff were each assigned a weight of 0.25. These parameters were calculated using Paddicks conformity index (CI) 16 and a dose falloff (FO) 17 variable which are defined as:
where TV is the treated volume, PIV is the volume that receives the prescription isodose, TV PIV is the treated volume that overlaps with the PIV (TV ∩ PIV) and V 50 is the volume that receives 50% of the prescription dose.
If the achieved DVH, CI, or FO value was below the constraint value then it was removed from the cost function. This formulation of the cost function allows one to control the relative importance of CI and FO objectives while the DVH constraints are of unconstrained magnitude. The CI and FO difference terms represented in Eq. (1) will be of order unity so they each have approximately 25% contribution of the total cost. While there are other ways of achieving this goal (i.e., adding the conformity index in quadrature, but with variable weighting terms, or various methods described by 18 ), we found this method successfully and consistently produced plans of sufficient quality without any need of extra variables or complex methods.
2.B. Plan comparisons
2.B.1. Patient selection
Ten patients summarized in Table I that were previously treated in 2014 with DCA at our institution were selected for this study. These patients were anonymized and re-planned with the TVMAT method. Patient selection was designed to encapsulate a wide variety of cases to account for different planning considerations. There was diversity in disease sites with three acoustic neuromas (AN), 3 single metastasis (met) and 4 multiple met cases. Lesion size varied from 0.3 cm 3 to 12 cm 3 with a median volume of 3.4 cm 3 . Tumor dose varied between 12 Gy to 24 Gy delivered in a single fraction treatment. The original DCA plans were planned using the iPlan TPS (BrainLAB AG) with one isocentre at the centre of mass of each PTV. The DCA plans were exported to the Varian Eclipse TPS, and dose calculations were performed using the analytical anisotropic algorithm (AAA) without homogeneity correction. Each plan had between three and nine partial arcs per plan which took approximately 15 to 40 min to treat. For comparison purposes, plans were also replanned using the "4 Arc" VMAT geometry presented in 5 with the same optimization methodology (cost function, treatment planning algorithms) of this study.
2.B.2. Treatment comparison
The primary goal in the development of this method was to reproduce the dosimetric results of the DCA method and then judicially try to outperform them in a selected subset of clinical variables. To do this, The OAR portion of the cost function were based on the clinically achieved outcomes of the original DCA plans. The OARs DVH of the DCA plans were discretized into a set of constraints which were loaded into the optimizer. DVH dose constraints for the OARs were scaled by 90% of the clinically achieved values both to account for minor differences between dose calculation engines (our in-house code and Varian AAA) and to ensure an outperformance of the clinical plans. The optimal Conformity index, CI OPT, was set to 1 which corresponds to only the PTV receiving the prescription dose. The value for the most optimal falloff (FO OPT) was set to 2.
2.C. Validation of deliveries
The optimized plans' were exported as static beams to Varian Eclipse, and doses were calculated using the AAA with dose voxel spacing of 0.1 cm. These control points were spaced every three couch-gantry degrees which we found approximated a dynamic delivery. While control point weights were maintained, plans were renormalized so that the minimum dose to the PTV was the prescription dose (plan quality set to 1). A subset of the patients (patient 1, 2 and 6) were selected for dose measurement verification. Due to the fact that Varian has not yet released dynamic couch motion for clinical deliveries, these measurements were performed in Developer Mode. Prior to delivery, machine commissioning procedures were conducted to ensure the linac was within tolerances for SRS deliveries. Dynamic couch picket fence analysis 19 as well as an isocentre stability measurement 20 was conducted. The dynamic couch picket fence test was indistinguishable from picket fence conducted without movement. Using the stability measurement, 20 we found a max couch walkout of 0.4 mm with mean value of 0.2 mm.
Plans were exported as control points and translated into xml format. Next, the treatments were delivered on a cube phantom measuring 18.5 9 18.5 9 18.5 cm 3 for ion chamber and film measurements. Ion chamber measurements were performed with an IBA CC01 chamber with sensitive volume of 0.01 cm 3 . GaFchromic EBT3 film measurements were performed along the sagittal and the coronal planes passing through the isocentre. Gamma analysis 21 was conducted using 2%, 2 mm passing criterion with a 10% minimum dose threshold.
Trajectory-log analysis of the delivered plans was conducted and compared to the trajectory beam parameters of the treatment plans. This was done by comparing the expected positions of the beam axes (patient support angle, gantry rotation angle, MLC leaf positions) to the axes position that were recorded in the trajectory-log files during the delivery of the plans. We compared the deliveries at each control point of the delivered plan. Each control point had a cumulative MU, couch angle and gantry angle (and other beam parameters not compared in this study). The cumulative MU of each CP was found in the trajectory-log time series (AE 0.01 MU) and the recorded gantry and couch angles at these time points were compared to the expected values. The root mean squared error (RMSE) was calculated for these parameters.
RESULTS
3.A. Treatment comparison
3.A.1. Treatment comparison to dynamic conformal arcs
Overall the developed TVMAT method was able to produce plans with similar or better dosimetric indices when compared to the DCA plans. A typical dose distribution comparison is shown in Fig. 2 which corresponds to patient 3. From this comparison, one can see that TVMAT produced more isotropic falloff. In addition, the prescription isodose conformed more closely to the PTV. For this particular plan, dose rate modulation was successfully used to subtly reduce dose to the abutting brainstem structure while not compromising other planning metrics.
An overview of the PTV and normal tissue dose statistics are shown in Table II . Planning metrics varied widely due to the variation in the location, size and number of PTVs for each respective patient. When comparing TVMAT to the DCA method using the Wilcoxon sign-rank (WSR) test, we found an increase in dose conformity from 0.65 to 0.72 (P < 0.01), with an average improvement (mean AE 2SE) by 10 AE 2%. Dose falloff results decreased but not significantly. TVMAT plans had a mean of 3.12 while DCA plans had a mean of 3.27, which surmounted to an improvement by 4 AE 2% between the two treatment options. Dose homogeneity indices were similar for both techniques with an average value of 1.23 for TVMAT and 1.27 for DCA (% improvement = 3 AE 2%). If one refers to (Table II) , one can see the majority of patients had an improvement in V4 (P < 0.05) and V12 (P < 0.01) values. This resulted in a percent improvement of 20 AE 10% for V 4Gy and 27 AE 10% for V 12Gy . An overview of the significant improvements is shown in Fig. 3 . Doses to OAR varied widely between treatments due to location of the indications with respect to the organs. Therefore, it was not possible to find any trends in dosimetric values with the sample size used in this study. The DCA plans, VMAT and the TVMAT plans all conformed to QUANTEC 22 values. In addition, there was a non-significant improvement in the volume weighted mean dose to OAR of 13 AE 13%. Further planning studies with larger patient numbers are required to find if there is a relationship between this method and reduction of OAR doses.
3.A.2. Treatment comparison: volumetric modulated arc therapy
The TVMAT performed similarly to VMAT when one compares dosimetric indices of (Table II) (P > 0.1 for all indices using WSR). There were no appreciable differences between any of the evaluated quantitative values of the two methodology. The differences are summarized (average % difference AE standard error): conformity (0.7 AE 3%), Homogeneity (0.2 AE 0.7%), Falloff (2 AE 2%), V12 (2 AE 2%), and V4 (5 AE 3%). This similarity in dosimetric indices was expected due to the fact that the two methods have very similar beam geometries. This suggests that the main benefits of this technique over VMAT are only in efficiency of delivery. Figure 4 shows the impact of the number of partial arcs on the optimized cost for selected number of cases. In all test patients, the optimization algorithm found a cost minimum with less than eight partial arcs. This suggests that the eight arc plan adequately samples the phase space and fewer arcs can produce the plans with the same optimized cost values. In the case of the three Acoustic Neuroma patients, fairly reproducible results were observed patient to patient. In this subset of patients, [ Fig. 4(a) ] the cost showed a decay structure which came very close to a minimum at three partial arcs and reached an absolute minimum value at four partial arcs. Certain variables shown in Fig. 4 (b) were optimized with even fewer partial arcs. The falloff, conformity and homogeneity were minimized at two partial arcs. This trajectory corresponds to the one previously studied by Podgorsak. 6 In this trajectory, the gantry and couch both rotate at a constant velocity producing a baseball stitch pattern across the head. The Podgorsak trajectory reportedly produces a spherical dose distribution with isotropic falloff. 6 While the falloff, conformality and homogeneity were optimized with fewer partial arcs, the cost was minimized at four partial arcs for the AN patients. These deliveries had an adequate sampling of the phase space such that they could simultaneously avoid critical structures while having enough entrance angles to provide falloff, conformity, and homogeneity.
3.B. Analysis of trajectories
3.C. Validation of deliveries
The results of the dosimetric measurements for patients 1, 2, and 6 are presented in Table III . Isocentric ion chamber measurements were within 2% of measured values for all patients. Uncertainties were mainly attributed to uncertainties in small field delivery and the variation of the stem effects of the chamber with beam angle. Film measurements provided dose distribution information which agreed well with the expected values. Sample dose distribution and profile data are shown in Fig. 5 . Dose distributions were compared with gamma analysis (2%, 2 mm passing criterion) and achieved a 98% passing rate on average (Table III) . For each of the subsequent deliveries, trajectory logs were collected. The recorded couch and gantry angle were compared with the expected couch and gantry angles. The root mean square deviation of these values was compared. Interestingly, the trajectory log recorded gantry and couch values were an order of magnitude closer to their expected values than the machines set tolerances. 
DISCUSSION
The TVMAT technique presented here is an inverse planning method that produces an optimal treatment plan by using MLC and dose rate modulation along a pre-defined, over-sampled trajectory. Via dose rate modulation, the optimization technique indirectly determines an optimized beam trajectory by allowing beam delivery only for optimal beam entrance angles. Our preliminary treatment planning study has shown the dosimetric advantages of TVMAT when compared to the DCA technique due to the increase in conformity, homogeneity while maintaining falloff, and OAR Doses. While there were no dosimetric advantage of TVMAT over VMAT, treatment deliveries are more efficient. This is due to there being no need for multiple couch repositionings.
This method attempts to minimize patient discomfort and movement by constraining the device and treatment plan to have couch rotations in the same direction and theoretically have minimal inertial forces acted on the patient. This will be more comfortable and quicker than multiple static arcs as the patient will have to undergo shorter treatments with less number of accelerations. However, while the deliveries in this study tried to limit the accelerations of the couch, the linac control system allows only for the specification of the location of the linacs degrees of freedom in the form of control points, leaving velocities and accelerations up to the control of the device. If one wanted to truly limit accelerations felt by the patient, linac manufacturers would need to release control of these features.
The treatment couch walkout can affect the accuracy of the TVMAT delivery technique and should be accurately characterized during commissioning of this technique. The couch walkout of the TrueBeam linac on which this study was conducted was less than 0.4 mm. While this error is relatively small when compared with patient setup error, it should still be considered in the determination of the PTV margin. If couch walkout is a significant contributor to isocentre localization accuracy then dynamic couch deliveries should not be conducted due to the inability to correct for these errors as one possibly could in static couch deliveries.
Some of this work is preliminary, and further improvements to the optimization method and a more comprehensive treatment planning study with larger sample sizes are needed to determine the full dosimetric benefits of this technique. Additional improvements of this method will incorporate single isocentre treatment planning for multiple metastases. However, for the single isocentre technique, accurate rotational accuracy in patient setup is of paramount importance as small rotational errors can result in large dosimetric errors when the PTVs are far from the isocentre. 23 Preliminary results presented in this paper in trajectory-log analysis suggest that the machine delivery inaccuracies will be insignificant when compared to patient setup inaccuracies; however, the accuracy of these trajectory logs have not been independently verified and these results should only be used as a consistency check. Once implemented, these treatments will allow the treatment of larger number of targets (more than 3) 24 in a time efficient manner.
CONCLUSION
We have developed and validated a trajectory-based dose delivery method which has dose distribution improvements while having a treatment time of between 3 to 8 min. In addition, it has the potential to make the way for a more efficient treatment planning process while maintaining an accurate delivery on the Varian Truebeam Linac. 
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